Tom Cohen

Teon Tx and MSD Partner in Oral IO Clinical Trial

—

by

Tom Cohen
in

Teon Tx and MSD will partner to study a combination of a new immune-modifier and existing anti-PD-1 immune checkpoint inhibitor.

Read More

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *